Items where authors include "Bibi, S."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Hornsby, H. orcid.org/0000-0002-6657-9743, Nicols, A.R. orcid.org/0000-0002-1813-3819, Longet, S. orcid.org/0000-0001-5026-431X et al. (40 more authors) (2023) Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history. Nature Communications, 14 (1). 5065. ISSN 2041-1723

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956

Dijokaite-Guraliuc, A., Das, R., Zhou, D. et al. (44 more authors) (2023) Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses. Cell Reports, 42 (4). 112271. ISSN 2211-1247

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Moore, S.C. orcid.org/0000-0001-8610-2806, Kronsteiner, B., Longet, S. et al. (61 more authors) (2023) Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. Med, 4 (3). 191-215.e9. ISSN 2666-6340

Huo, J., Dijokaite-Guraliuc, A., Liu, C. et al. (34 more authors) (2023) A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75. Cell Reports, 42 (1). 111903. ISSN 2211-1247

Mentzer, A.J. orcid.org/0000-0002-4502-2209, O’Connor, D. orcid.org/0000-0002-6902-9886, Bibi, S. et al. (66 more authors) (2023) Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nature Medicine, 29 (1). pp. 147-157. ISSN 1078-8956

Tran, K.B., Lang, J.J., Compton, K. et al. (1020 more authors) (2022) The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 400 (10352). pp. 563-591. ISSN 0140-6736

Barton, A., Hill, J., Bibi, S. et al. (12 more authors) (2022) Genetic susceptibility to enteric fever in experimentally challenged human volunteers. Infection and Immunity, 90 (4). ISSN 0019-9567

Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736

Adams, E.R., Ainsworth, M., Anand, R. et al. (69 more authors) (2020) Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel [version 1; peer review: 2 approved]. Wellcome Open Research, 5. 139. ISSN 2398-502X

Lagkas, T. orcid.org/0000-0002-0749-9794, Argyriou, V., Bibi, S. et al. (1 more author) (2018) UAV IoT Framework Views and Challenges: Towards Protecting Drones as "Things". Sensors, 18 (11). 4015. ISSN 1424-8220

Tuijnenburg, P., Lango Allen, H., Burns, S.O. et al. (85 more authors) (2018) Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. Journal of Allergy and Clinical Immunology, 142 (4). pp. 1285-1296. ISSN 0091-6749